Advertisement

Brand-name drugs for glaucoma more costly than generics

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Malvankar-Mehta MS, et al. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. ClinicoEconomics and Outcomes Research 2019: 789-798, No. 11, 16 Dec 2019. Available from: URL: https://doi.org/10.2147/CEOR.S156558

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Brand-name drugs for glaucoma more costly than generics. PharmacoEcon Outcomes News 844, 9 (2020). https://doi.org/10.1007/s40274-020-6472-7

    Download citation